Attachment 8 NIH Notice Noninvasive Only1

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences, National
Cancer Institute.
Date: March 7, 2016.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C-Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad Tondravi, Ph.D.,
Chief, Institute Review Office, Office of the
Director, National Cancer Institute, National
Institutes of Health, 9609 Medical Center
Drive, Room 3W302, Rockville, MD 20850,
240–276–5660, [email protected].
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology, National Cancer Institute.
Date: March 8, 2016.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, C Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Executive Secretary, Institute Review Office,
Office of the Director, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414,
Rockville, MD 20850, 240–276–5660,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02534 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

mstockstill on DSK4VPTVN1PROD with NOTICES

National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and

VerDate Sep<11>2014

17:54 Feb 08, 2016

Jkt 238001

the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Neurosciences.
Date: March 11, 2016.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20892, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Clinical, Behavioral and
Epidemiological Studies.
Date: March 14, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—Biomedical Sciences.
Date: March 16, 2016.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health—
NIAAA, 5635 Fishers Lane, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

6873

Dated: February 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–02539 Filed 2–8–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The Use of Chimpanzees in NIHSupported Research
This notice provides
information on the National Institutes of
Health’s (NIH) reassessment of the need
to maintain a colony of 50 chimpanzees
for future research and decision to no
longer maintain a chimpanzee colony
for research. This notice also provides
information on conforming updates and
procedures related to this action.
FOR FURTHER INFORMATION CONTACT: The
Division of Program Coordination,
Planning, and Strategic Initiatives,
Office of the Director, National
Institutes of Health at dpcpsi@
od.nih.gov.
SUMMARY:

On
November 18, 2015, the NIH announced
it will no longer maintain a colony of 50
chimpanzees for future research and
that all NIH-owned chimpanzees that
reside outside the federal sanctuary
system operated by Chimp Haven,
Keithville, Louisiana, are eligible for
retirement. Relocation of the
chimpanzees to the federal sanctuary
system will be conducted as space is
available and on a timescale that will
allow for optimal transition of each
individual chimpanzee with careful
consideration of their welfare, including
their health and social grouping. See the
NIH Director’s statement at https://www.
nih.gov/about-nih/who-we-are/nihdirector/statements/nih-will-no-longersupport-biomedical-researchchimpanzees. Consistent with this
decision, the NIH is limiting its future
support for research using chimpanzees
to that which would be permissible in
the federal sanctuary system under the
Chimpanzee Health Improvement,
Maintenance and Protection (CHIMP)
Act and the implementing regulations at
42 CFR part 9. Such research must
either be noninvasive behavioral studies
or medical studies based on information
collected during the course of normal
veterinary care that is provided for the
benefit of the chimpanzee, provided that
any such study involves minimal
physical and mental harm, pain,
distress, and disturbance to the

SUPPLEMENTARY INFORMATION:

E:\FR\FM\09FEN1.SGM

09FEN1

mstockstill on DSK4VPTVN1PROD with NOTICES

6874

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices

chimpanzee and the social group in
which the chimpanzee lives.
Specifically, permissible research, as
described in the ‘‘Standards of Care for
Chimpanzees Held in the Federally
Supported Chimpanzee Sanctuary
System’’ at 42 CFR part 9, includes:
• Visual observation;
• Behavioral studies designed to
improve the establishment and
maintenance of social groups. These
activities may cause stress as a result of
novel interactions between chimpanzees
and caregivers, but they are not
considered invasive as long as they are
intended to maximize the well-being of
the chimpanzees;
• Medical examinations as deemed
necessary to oversee the health of the
chimpanzees, in the least invasive
manner possible. Collection of samples
routinely obtained during a physical
examination for processing during this
time is also considered noninvasive
since a separate event is not required;
• Administration and evaluation of
environmental enrichment used to
promote the psychological well-being of
the chimpanzees; and
• Actions taken to provide essential
medical treatment to an individual
chimpanzee exhibiting symptoms of
illness. This applies only to serious
illness that cannot be treated while the
chimpanzee remains within the colony.
• Observational studies and
collection of biomaterial in the wild
without interfering with the chimpanzee
is also permitted.
These decisions apply to all new or
competing renewals of grant
applications, contract proposals,
intramural protocols, and 3rd party
projects. The NIH may issue future
guidance about the permissible
noninvasive research involving
chimpanzees. Researchers are
encouraged to contact their program
officers for additional information or the
Division of Program Coordination,
Planning, and Strategic Initiatives at
[email protected].
The NIH’s decision to allow the
support of noninvasive research
involving the use of chimpanzees, as
described in this notice, does not affect
requirements for investigators and/or
their institutions to obtain permits from
the U.S. Fish and Wildlife Service, if
applicable, nor does it affect the
responsibility to meet all applicable
veterinary, colony, and husbandry
obligations.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Human Genome Research
Institute; Notice of Closed Meetings

Submission for OMB Review; 30-Day
Comment Request; Application Forms
for the NIDA Summer Research
Internship Program

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, KOMP2 (Knockout Mouse
Phenotyping Program).
Date: March 3, 2016
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NHGRI, 5635FL, NHGRI Twinbrook
Library, Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lita Proctor, Ph.D.,
Extramural Research Programs Staff, Program
Director, Human Microbiome Project,
National Human Genome Research Institute,
5635 Fishers Lane, Suite 4076, Bethesda, MD
20892, 301 496–4550, proctorlm@
mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, Sequencing Technology Special
Emphasis Panel.
Date: March 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott at Reagan
National Airport, 1999 Salon E & D, Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)

Dated: February 2, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.

Dated: February 4, 2016.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2016–02554 Filed 2–8–16; 8:45 am]

[FR Doc. 2016–02538 Filed 2–8–16; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

VerDate Sep<11>2014

17:54 Feb 08, 2016

Jkt 238001

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on September 2,
2015, Vol. 80, No. 170, on page 53164.
No comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute of Drug Abuse
(NIDA), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to Omb: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed program,
contact: Albert Avila, Ph.D., Director,
Office of Diversity and Health
Disparities, NIDA, NIH, 6001 Executive
Blvd., Room 3106, Rockville, MD 20852,
or call non-toll-free number (301)–443–
0441 or Email your request, including
your address to: [email protected].
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: NIDA Summer
Research Internship Program 0925Existing Collection in Use Without an
OMB Control Number, National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH).
SUMMARY:

E:\FR\FM\09FEN1.SGM

09FEN1